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BIOTECHNOLOGY AND THE 
ENVIRONMENTAL VISION
In the spirit of Walter Truett Andersen’s talk, I hope to provide a respon-
sible contribution to the ongoing debate whose long evolution he has 
described.
I have enjoyed the opportunity occasioned by this speech to take a some-
what longer view of biotechnology; to reflect 
on how far it has come and where it might be 
going. In so doing, I have pondered two ques-
tions. The first is the question of my vision of 
the future of biotechnology. The second con-
cerns the idea of a crossroads—whether, in-
deed, biotechnology is at a crossroads.
On the question of my vision of the future of 
biotechnology, I need at the outset to rephrase 
the question, for I do not have a vision of the 
future of biotechnology. Biotechnology is a col-
lection of tools, capabilities and products. In 
my view the vision should focus not on tools, 
but on how we want to use them.
My vision is not of biotechnology but of a new 
kind of agriculture—a sustainable agriculture—with characteristics and 
objectives different from the industrial agriculture currently practiced. 
The important question is whether the tools and products of biotechnol-
ogy advance us towards that vision.
What is the vision? It centers on prosperous farmers, an abundance of 
safe food and a clean environment. In it, clean—not polluted—water 
washes off agricultural fields and percolates through the soil to the 
groundwater below. Wildlife thrives at the edge of fields, rather than dying 
from consuming pesticide pellets. Weeds are in the fields, but kept to levels 
that do not interfere with yields. Cultural practices and intelligent man-
agement control the interaction between pests and crops. Agriculture de-
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velops in response not to short term goals—tempting as that always is— 
but with an eye to long term productivity and prosperity.
Such an agriculture will depend on methods that will be as viable 50 
years from now as they are today. It will look for ways to use and reuse ma-
terials on the farm. It will put a premium on information and manage-
ment rather than on purchased inputs.
Such an agriculture will be supported by a revitalized and redirected 
land grant university system. The new land grant universities will be able 
to provide information about cultural and integrated farming practices as 
readily as today’s land grant universities disperse information about 
chemical pesticides. These new land grant universities will command a 
much larger part of our national research pie because they will be seen as 
ensuring not only agricultural productivity but a healthful environment, 
safe food, and a connection to nature for our increasingly urbanized 
populations. Land grants with this new broader vision of their mission 
would be at the forefront of our national life rather than in the backwater.
My vision for the future of agriculture also includes a varied, abundant 
and safe food supply with which people are comfortable. Consumers 
would not need to wonder whether the carrots they picked up at the mar-
ket had mouse or human genes in them. Nor would they need to worry 
about whether the tomatoes they were eating contained a toxin gene inad-
vertently transferred into the tomatoes by careless genetic engineers.
Where does biotechnology fit into this picture? So far, at least, biotech-
nology will not substantially advance us toward a sustainable agriculture. 
Let’s look at the four categories of products that are the subjects of work-
shops at this meeting. Herbicide-tolerant crops, animal growth promo- 
tants, transgenic animals and biological control agents. Three of the 
four—herbicide-tolerant crops, animal growth promotants, and trans-
genic animals—could easily be dispensed with without retarding our 
progress toward a sustainable agriculture. The fourth, biological control 
agents, is an important component of a sustainable agriculture but 
biotechnology will have only a minor impact on the efficacy and adoption 
of such agents.
I am not saying that the products of biotechnology have no place in a 
sustainable agriculture. Some, for example pest-resistant crops, could
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be important components of such systems. But right now, in 1991, the 
available biotechnology products are not contributing significantly to the 
development of sustainable agriculture. Some, such as herbicide-tolerant 
crops, are antithetical to that vision.
Biotechnology is dampening our progress towards sustainable agricul-
ture in a more subtle way, meaning that biotechnology is popular with 
government, universities and private industry because of its potential to 
generate new products. For example, companies and universities cur-
rently spend millions to develop new biological pesticides. In general, 
these products—although not without problems—are environmentally 
preferable to existing chemical pesticides. But at the crux of the matter, 
the new pesticide products are not the best solution to the problem of 
pests. It is widely agreed that systems approaches—for example, crop ro-
tation and other methods—could avoid the need for the majority of pesti-
cides, both chemical and biological, now and into the future. The problem 
is that the hype surrounding biotechnology diverts our attention from 
those solutions by focusing attention on technologically dazzling new 
products. The bias towards products deprives the systems-based ap-
proaches of the research and extension resources that are required to 
achieve their full potential.
It is vital that agricultural policy put biotechnology in a position to 
serve and not displace sustainable agriculture. The question should not be 
whether biopesticides are compatible with sustainable agriculture, but 
whether, after crop rotations have been employed to their fullest, which 
pesticides are still needed.
To offer a metaphor for nature of the choice we have before us—bio-
technology can be considered an elephant standing in front of two tents. 
One tent is large enough for the elephant, but it is also somewhat rickety.
It has stood for a while, but will not last much longer. It is the tent of in-
dustrial agriculture.
The other tent is smaller, not as glitzy, but sturdy. It will last as far into 
the future as we can see. But it will not hold the biotechnology elephant. If 
the elephant charges in, the sustainable agriculture tent will come tum-
bling down. What is needed is to put the biotechnology elephant on a diet, 
to cut it down to size so that it will fit into the sturdy tent. Specifically, the
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United States Department of Agriculture (USDA) should not be distribut-
ing buttons emblazoned with “Biotechnology is the Future of Agricul-
ture.” Biotechnology cannot be the future of agriculture. Technologies 
have no values; they embody no goals. And yet they are not neutral in their 
application. Technology can influence outcomes, particularly if the tools 
themselves are mistakenly regarded as goals.
It is time to articulate a vision of sustainable agriculture and ask how 
best to achieve it. Our goal should not be merely more new pesticides but 
a 75 percent reduction in pesticide use. By setting the proper goal, we will 
avoid the danger of spending millions trying to genetically engineer ten 
“better” pesticides, when for far less we could have taken our agriculture 
systems off the pesticide treadmill forever.
My second point concerns the idea of a crossroads. Is agricultural bio-
technology, specifically the industry sector concentrated on transgenic 
plants and animals—really at a crossroads? In some ways, I would say not. 
The molecular biological and genetic sciences underpinning the technol-
ogy are advancing at an accelerating pace. New scientific discoveries are 
leading to a stream of new products. The pace is slower than promised by 
the optimistic early entrepreneurs—but as the numerous field tests dem-
onstrate, new products, especially engineered crops, are coming. A mean-
dering path, perhaps, but not a crossroads.
A crisis looms for agricultural biotechnology in the area of product 
commercialization. This crisis could constitute a genuine crossroads. If 
the products now in the pipeline can make their way soon to the market-
place, the industry will develop confidence and attract new investors. On 
the other hand, if the early products are delayed in getting to the market-
place or are received unfavorably, the whole industry would be set back. 
The key is the federal review system. Without credible government review 
to assure safety, the pioneer products of biotechnology will never make it 
to the marketplace.
Despite almost a decade of federal level effort, the biotechnology regu-
latory system is in shambles. With regard to animals, such as fish, regula-
tion is non-existent. With regard to food, authority exists and the govern-
ment is aware that policy is needed, but it is proceeding at a glacial pace. 
Even where it appears to be functioning, the government is sometimes at
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the edge of its capabilities. In the crop plant area, for example, the USDA 
has overseen more than 200 field tests of engineered crops under the Plant 
Pest Act. While those tests generally have been conducted efficiently and 
safely, the Agency is facing an impasse in providing approvals for com-
mercialization. The impasse is primarily attributable to limitations in the 
Plant Pest Act. Whatever the reason, the USDA has failed to describe a 
program for commercialization approvals. Open issues are legal authority 
for regulation, data requirements and opportunities for public comment. 
Lacking risk assessment protocols for large and commercial scale release, 
it is not surprising that the small scale tests done so far have not yielded 
many data on environmental risks. New rounds of small scale tests will 
probably have to be done to generate those data.
This is just one of the uncertainties facing those who want to commer-
cialize transgenic crops. For example, later this month Environmental 
Protection Agency (EPA), USDA and the Food and Drug Administration 
(FDA) will meet for the first time to discuss the potential statutory over-
laps on herbicide-tolerant plants. If the agencies are just beginning to ad-
dress these issues, it means that proposed and final rules are years away, at 
best. This regulatory quagmire is beginning to assume crisis proportions. 
The issue of when, if ever, a reliable regulatory road map will be ready is 
becoming the rate-limiting factor in product development.
I am of mixed mind about the slowdown in the rate of the technology’s 
development. If it were to result in a shift of resources to the system ap-
proach of a sustainable agriculture, I would consider it a boon. But I 
doubt that would be the outcome. More likely scientists will become im-
patient and like Gary Stroebel, will go ahead with releases on their own. 
That prospect is one of great concern.
To finish, let me summarize my two points. First, the agricultural bio-
technology industry appears to be approaching a genuine crossroads in 
the area of commercialization. If the government cannot come up with 
protective, credible regulatory programs soon, transgenic products will 
not reach the marketplace and agricultural biotechnology will suffer a ma-
jor setback. Second, our vision should focus on a low-input sustainable 
agriculture, not the course of a particular technology. I hope that under 
the leadership of the land-grant universities, biotechnology will be made
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to play second fiddle in the orchestra of sustainable agriculture. If it does, 
we can look forward to a symphony of environmentally and practically 
sound agricultural practices.
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